Literature DB >> 8101494

Regulation by dexamethasone of P-glycoprotein expression in cultured rat hepatocytes.

O Fardel1, V Lecureur, A Guillouzo.   

Abstract

We have examined P-glycoprotein (P-gp) expression and function in cultured rat hepatocytes in response to dexamethasone (DEX), which is known to modulate various liver functions. Northern blot analyses revealed high levels of P-gp mRNAs in cultured untreated liver cells in comparison to those found in freshly isolated hepatocytes, while DEX-treated hepatocytes also displayed elevated, although weaker, P-gp levels. Similarly, Western blotting analysis indicated high levels of P-gp in liver cells maintained in the absence of DEX. The use of mdr gene-specific probes allowed us to show that DEX-modulated P-gp induction in cultured hepatocytes involved mostly, if not specifically, mdr1 gene regulation. Doxorubicin P-gp-mediated efflux analyses revealed lower intracellular doxorubicin accumulation in DEX-untreated liver cells than in DEX-treated cells, thus indicating that over-expressed P-gp was functional. These data clearly show that DEX treatment strongly modulates P-gp expression in primary rat hepatocyte cultures through a specific effect on the mdr1 gene.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8101494     DOI: 10.1016/0014-5793(93)80167-s

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

Review 1.  Role of P-glycoprotein in pharmacokinetics: clinical implications.

Authors:  Jiunn H Lin; Masayo Yamazaki
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Overexpression of P-glycoprotein in heat- and/or drug-resistant hepatoma variants.

Authors:  M Pirity; A Hevér-Szabó; A Venetianer
Journal:  Cytotechnology       Date:  1996       Impact factor: 2.058

3.  Exposure of LS-180 cells to drugs of diverse physicochemical and therapeutic properties up-regulates P-glycoprotein expression and activity.

Authors:  Alaa H Abuznait; Shawn G Patrick; Amal Kaddoumi
Journal:  J Pharm Pharm Sci       Date:  2011       Impact factor: 2.327

4.  The effect of 3435C>T MDR1 gene polymorphism on rheumatoid arthritis treatment with disease-modifying antirheumatic drugs.

Authors:  Marek Drozdzik; Tomasz Rudas; Andrzej Pawlik; Mateusz Kurzawski; Bogusław Czerny; Wanda Gornik; Magdalena Herczynska
Journal:  Eur J Clin Pharmacol       Date:  2006-08-24       Impact factor: 2.953

5.  Effect of ethanol on regulation of (Na + K)-adenosine triphosphatase by aldosterone and dexamethasone in cultured renal papillary collecting duct cells.

Authors:  Ramón Rodrigo; Gonzalo Rivera; Yalola Lucero; Constanza Larraguibel
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

6.  Phase I trial of lenalidomide and CCI-779 in patients with relapsed multiple myeloma: evidence for lenalidomide-CCI-779 interaction via P-glycoprotein.

Authors:  Craig C Hofmeister; Xiaoxia Yang; Flavia Pichiorri; Ping Chen; Darlene M Rozewski; Amy J Johnson; Seungsoo Lee; Zhongfa Liu; Celia L Garr; Erinn M Hade; Jia Ji; Larry J Schaaf; Don M Benson; Eric H Kraut; William J Hicks; Kenneth K Chan; Ching-Shih Chen; Sherif S Farag; Michael R Grever; John C Byrd; Mitch A Phelps
Journal:  J Clin Oncol       Date:  2011-08-08       Impact factor: 44.544

7.  Influence of rat strain on P-glycoprotein expression in cultured hepatocytes.

Authors:  E Chieli; N Romiti; F Cervelli; A Paolicchi; R Tongiani
Journal:  Cell Biol Toxicol       Date:  1994-06       Impact factor: 6.691

8.  Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells.

Authors:  P Martin; R Riley; D J Back; A Owen
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

9.  Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier.

Authors:  Vishal S Narang; Charles Fraga; Narendra Kumar; Jun Shen; Stacy Throm; Clinton F Stewart; Christopher M Waters
Journal:  Am J Physiol Cell Physiol       Date:  2008-06-04       Impact factor: 4.249

Review 10.  Anthracycline antibiotics in cancer therapy. Focus on drug resistance.

Authors:  D J Booser; G N Hortobagyi
Journal:  Drugs       Date:  1994-02       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.